Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment

Neurobiology of Aging

Volumn 30, Issue 9, 2009, Pages 1430-1443

  Young, Jared W ^a   Sharkey, John ^a   Finlayson, Keith ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aging; Alzheimer's disease; Mild Cognitive Impairment; Olfaction; Tg2576; Working memory

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MOUSE; NONHUMAN; OLFACTORY DISCRIMINATION; OLFACTORY MEMORY; PRIORITY JOURNAL; SMELLING DISORDER; TASK PERFORMANCE; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; LEARNING DISORDERS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROPSYCHOLOGICAL TESTS; ODORS; SMELL;

EID: 67650604202     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.11.018     Document Type: Article

References (54)

1. Apelt J., Kumar A., and Schliebs R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res. 953 (2002) 17-30
2. Arendash G.W., and King D.L. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiol. Behav. 75 (2002) 643-652
3. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., and Diamond D.M. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891 (2001) 42-53
4. Arendash G.W., Garcia M.F., Costa D.A., Cracchiolo J.R., Wefes I.M., and Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15 (2004) 1751-1754
5. Ashe K.H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8 (2001) 301-308
6. Baddeley A. Working Memory (1986), Oxford Press, Oxford
7. Bliwise D.L., and Swan G.E. Habitual napping and performance on the Trail Making Test. J. Sleep Res. 14 (2005) 209-210
8. Braak H., and Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16 (1995) 271-278 (discussion 8-84)
9. Cave C.B., and Squire L.R. Intact verbal and nonverbal short-term memory following damage to the human hippocampus. Hippocampus 2 (1992) 151-163
10. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., and Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2 (1999) 271-276
11. Chong M.S., and Sahadevan S. Preclinical Alzheimer's disease: diagnosis and prediction of progression. Lancet Neurol. 4 (2005) 576-579
12. Davies P., and Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2 (1976) 1403
13. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 (1990) 457-464
14. DeKosky S.T., Harbaugh R.E., Schmitt F.A., Bakay R.A., Chui H.C., Knopman D.S., Reeder T.M., Shetter A.G., Senter H.J., and Markesbery W.R. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Ann. Neurol. 32 (1992) 625-632
15. Devanand D.P., Michaels-Marston K.S., Liu X., Pelton G.H., Padilla M., Marder K., Bell K., Stern Y., and Mayeux R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am. J. Psychiatry 157 (2000) 1399-1405
16. Dong H., Csernansky C.A., Martin M.V., Bertchume A., Vallera D., and Csernansky J.G. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology (Berl) 181 (2005) 145-152
17. Dudchenko P.A., Wood E.R., and Eichenbaum H. Neurotoxic hippocampal lesions have no effect on odor span and little effect on odor recognition memory but produce significant impairments on spatial span, recognition, and alternation. J. Neurosci. 20 (2000) 2964-2977
18. Fodero L.R., Saez-Valero J., McLean C.A., Martins R.N., Beyreuther K., Masters C.L., Robertson T.A., and Small D.H. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J. Neurochem. 81 (2002) 441-448
19. Fortin N.J., Agster K.L., and Eichenbaum H.B. Critical role of the hippocampus in memory for sequences of events. Nat. Neurosci. 5 (2002) 458-462
20. Gerlai R., and Clayton N.S. Analysing hippocampal function in transgenic mice: an ethological perspective. Trends Neurosci. 22 (1999) 47-51
21. Gilbert P.E., Barr P.J., and Murphy C. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease. J. Int. Neuropsychol. Soc. 10 (2004) 835-842
22. Herholz K., Weisenbach S., Kalbe E., Diederich N.J., and Heiss W.D. Cerebral acetylcholine esterase activity in mild cognitive impairment. Neuroreport 16 (2005) 1431-1434
23. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., and Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29 (1999) 177-185
24. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
25. Jacobsen J.S., Wu C.C., Redwine J.M., Comery T.A., Arias R., Bowlby M., Martone R., Morrison J.H., Pangalos M.N., Reinhart P.H., and Bloom F.E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 5161-5166
26. Jankowsky J.L., Xu G., Fromholt D., Gonzales V., and Borchelt D.R. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 62 (2003) 1220-1227
27. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21 (2001) 372-381
28. Kesner R.P., Gilbert P.E., and Barua L.A. The role of the hippocampus in memory for the temporal order of a sequence of odors. Behav. Neurosci. 116 (2002) 286-290
29. King D.L., Arendash G.W., Crawford F., Sterk T., Menendez J., and Mullan M.J. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 103 (1999) 145-162
30. Lane R.M., Kivipelto M., and Greig N.H. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin. Neuropharmacol. 27 (2004) 141-149
31. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., Hersh L.B., Sapolsky R.M., Mirnics K., and Sisodia S.S. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120 (2005) 701-713
32. Lehman E.J., Kulnane L.S., and Lamb B.T. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobiol. Aging 24 (2003) 645-653
33. Levy D.A., Manns J.R., Hopkins R.O., Gold J.J., Broadbent N.J., and Squire L.R. Impaired visual and odor recognition memory span in patients with hippocampal lesions. Learn. Mem. 10 (2003) 531-536
34. Levy D.A., Hopkins R.O., and Squire L.R. Impaired odor recognition memory in patients with hippocampal lesions. Learn. Mem. 11 (2004) 794-796
35. Li L., and Tang B.L. Environmental enrichment and neurodegenerative diseases. Biochem. Biophys. Res. Commun. 334 (2005) 293-297
36. Moechars D., Lorent K., De Strooper B., Dewachter I., and Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15 (1996) 1265-1274
37. Moechars D., Gilis M., Kuiperi C., Laenen I., and Van Leuven F. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport 9 (1998) 3561-3564
38. Ohno M., Sametsky E.A., Younkin L.H., Oakley H., Younkin S.G., Citron M., Vassar R., and Disterhoft J.F. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41 (2004) 27-33
39. Patel N.V., Gordon M.N., Connor K.E., Good R.A., Engelman R.W., Mason J., Morgan D.G., Morgan T.E., and Finch C.E. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol. Aging 26 (2005) 995-1000
40. Perry E.K., Perry R.H., Blessed G., and Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 4 (1978) 273-277
41. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., and Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2 (1978) 1457-1459
42. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C.H., and Thal L.J. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352 (2005) 2379-2388
43. Samuel W., Terry R.D., DeTeresa R., Butters N., and Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch. Neurol. 51 (1994) 772-778
44. Simard M., and van Reekum R. Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease. Drugs Aging 14 (1999) 197-230
45. Slotnick B. Animal cognition and the rat olfactory system. Trends Cogn. Sci. 5 (2001) 216-222
46. Tabert M.H., Liu X., Doty R.L., Serby M., Zamora D., Pelton G.H., Marder K., Albers M.W., Stern Y., and Devanand D.P. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann. Neurol. 58 (2005) 155-160
47. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
48. Turchi J., and Sarter M. Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG-saporin-induced lesions on olfactory span performance. Eur. J. Neurosci. 12 (2000) 4505-4514
49. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly A., Van Paesschen W., and Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 277 (1997) 376-380
50. Vosshall L.B. Social signals: the secret language of mice. Curr. Biol. 15 (2005) R255-R257
51. Wisor J.P., Edgar D.M., Yesavage J., Ryan H.S., McCormick C.M., Lapustea N., and Murphy Jr. G.M. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 131 (2005) 375-385
52. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., and Sharkey J. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29 (2004) 891-900
53. Young J.W., Crawford N., Kelly J.S., Kerr L.E., Marston H.M., Spratt C., Finlayson K., and Sharkey J. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur. Neuropsychopharmacol. 17 (2007) 145-155
54. Young J.W., Kerr L.E., Kelly J.S., Marston H.M., Spratt C., Finlayson K., and Sharkey J. The odour span task: a novel paradigm for assessing working memory in mice. Neuropharmacology 52 (2007) 634-645